Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strategy (STRK) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Strategy (STRK) over the last 13 years, with Q3 2025 value amounting to $15.5 million.

  • Strategy's Share-based Compensation fell 2009.6% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.4 million, marking a year-over-year decrease of 1951.62%. This contributed to the annual value of $77.1 million for FY2024, which is 1085.65% up from last year.
  • Per Strategy's latest filing, its Share-based Compensation stood at $15.5 million for Q3 2025, which was down 2009.6% from $15.7 million recorded in Q2 2025.
  • Strategy's Share-based Compensation's 5-year high stood at $20.6 million during Q2 2024, with a 5-year trough of $7.7 million in Q1 2021.
  • Over the past 5 years, Strategy's median Share-based Compensation value was $15.7 million (recorded in 2025), while the average stood at $15.7 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 39847.26% in 2021, then plummeted by 3356.75% in 2025.
  • Strategy's Share-based Compensation (Quarter) stood at $13.2 million in 2021, then grew by 29.49% to $17.0 million in 2022, then grew by 15.76% to $19.7 million in 2023, then fell by 1.93% to $19.3 million in 2024, then decreased by 19.92% to $15.5 million in 2025.
  • Its last three reported values are $15.5 million in Q3 2025, $15.7 million for Q2 2025, and $11.8 million during Q1 2025.